Energy Drinks Plus Alcohol Tied to Brain Injury in Teens

This article originally appeared here.
Share this content:
Energy Drinks Plus Alcohol Tied to Brain Injury in Teens
Energy Drinks Plus Alcohol Tied to Brain Injury in Teens

FRIDAY, Sept. 18, 2015 (HealthDay News) -- The consumption of energy drinks and alcohol mixed with energy drinks increases the odds of traumatic brain injury (TBI) among adolescents, according to a study published Sept. 16 in PLOS ONE.

Gabriela Ilie, Ph.D., from St. Michael's Hospital in Toronto, and colleagues analyzed data from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey of 10,272 seventh- to 12th-graders (ages 11 to 20 years) to determine the prevalence of adolescent TBI and its associations with energy drinks, alcohol, and energy drinks mixed in with alcohol.

The researchers found that 22.4 percent of all students reported a history of TBI, with sports injuries accounting for most injuries in the past year (45.5 percent). However, based on multinomial logistic regression, relative to adolescents who never sustained a TBI, the odds of sustaining a recent TBI were greater for those consuming alcohol, energy drinks, and energy drinks mixed in with alcohol than for abstainers. The odds ratios for these behaviors were higher for students who sustained a recent TBI than for those who sustained a former TBI (lifetime but not past 12 months).

"TBI remains a disabling and common condition among adolescents and the consumption of alcohol, energy drinks, and alcohol mixed with energy drinks further increase the odds of TBI among adolescents," conclude the authors.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »